Human Metabolome Technologies (TSE:6090) Other Current Liabilities: 円147.8 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6090 Human Metabolome Technologies Inc TSE:6090
60 GF Score
Price 円594.00
GF Value 円530.94
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Human Metabolome Technologies Other Current Liabilities?

Human Metabolome Technologies TSE:6090 60 Other Current Liabilities is 円147.8 Mil as of Dec. 2025. GuruFocus rates TSE:6090 with a GF Score™ of 60/100 and a GF Value™ of 円530.94 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Human Metabolome Technologies's other current liabilities for the quarter that ended in Dec. 2025 was 円147.8 Mil.

Human Metabolome Technologies's quarterly other current liabilities declined from Jun. 2025 (円224.9 Mil) to Sep. 2025 (円143.8 Mil) but then increased from Sep. 2025 (円143.8 Mil) to Dec. 2025 (円147.8 Mil).

Human Metabolome Technologies's annual other current liabilities increased from Jun. 2022 (円174.8 Mil) to Jun. 2023 (円192.5 Mil) but then declined from Jun. 2023 (円192.5 Mil) to Jun. 2024 (円188.6 Mil).

Human Metabolome Technologies Other Current Liabilities Related Terms

Human Metabolome Technologies Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies Other Current Liabilities Chart

Human Metabolome Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 163.37 122.23 174.81 192.48 188.62

Human Metabolome Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 271.90 224.87 143.77 147.81 205.01
TSE:6090
60GF Score
Human Metabolome Technologies Inc TSE:6090
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Human Metabolome Technologies Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円147.8 Mil mean?
Human Metabolome Technologies (TSE:6090) has a Other Current Liabilities of 円147.8 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Human Metabolome Technologies.
Is Human Metabolome Technologies' Other Current Liabilities too high?
Human Metabolome Technologies' current Other Current Liabilities is 円147.8 Mil. Overall, Human Metabolome Technologies has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' Other Current Liabilities compare to TMO and DHR?
Human Metabolome Technologies' Other Current Liabilities of 円147.8 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Diagnostics & Research company?
A good Other Current Liabilities depends on the Medical Diagnostics & Research industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Human Metabolome Technologies. Human Metabolome Technologies's current Other Current Liabilities is 円147.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Overvalued. The stock's GF Value™ is 円530.94, compared to a current price of 円594.00 — trading 11.9% above its estimated fair value. The current Other Current Liabilities is 円147.8 Mil. Human Metabolome Technologies' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Other Current Liabilities is 円147.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be overvalued. The current stock price of 円594.00 is trading 11.9% above its estimated GF Value™ of 円530.94. GuruFocus considers Human Metabolome Technologies to be Modestly Overvalued.

Key valuation signals for TSE:6090:

  • Other Current Liabilities: 円147.8 Mil
  • GF Value™: 円530.94 vs. price of 円594.00 (11.9% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Human Metabolome Technologies Business Description

Address Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.
60GF Score

Get the complete analysis for TSE:6090

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円594.00
Price
円530.94
GF Value